<span class="fontstyle0">CD22 CAR-T salvage therapy for a refractory acute B lymphocytic leukemia patient with TP53#br# positive mutation and short-term recurrence after remission from CD19 CAR-T therapy</span> #br#

MU Juan, LYU Hai-rong, LI Jing-yi, JIANG Yan-yu, ZHANG Rui, MENG Juan-xia, YUAN Ting , DENG Qi

Tianjin Medical Journal . 2020, (4): 308 -312 . DOI: 10.11958/20192232